Significance of semiquantitative assessment of preformed donor-specific antibody using luminex single bead assay in living related liver transplantation

Clinical and Developmental Immunology

Volumn 2013, Issue , 2013, Pages

  Yoshizawa, Atsushi ^a   Egawa, Hiroto ^b   Yurugi, Kimiko ^c   Hishida, Rie ^c   Tsuji, Hiroaki ^c   Ashihara, Eiji ^c   Miyagawa Hayashino, Aya ^a   Teramukai, Satoshi ^c   Maekawa, Taira ^c   Haga, Hironori ^a   Uemoto, Sinji ^a  

^a KYOTO UNIVERSITY   (Japan)

^b TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^c KYOTO UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; DONOR SPECIFIC ANTIBODY; UNCLASSIFIED DRUG; ALLOANTIBODY; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL ARTICLE; COMPLEMENT DEPENDENT CYTOTOXICITY; FEMALE; HUMAN; INFANT; LIVER TRANSPLANTATION; LUMINEX BED ASSAY; MALE; MEAN FLUORESCENCE INTENSITY; MORTALITY; ORGAN DONOR; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK FACTOR; SCHOOL CHILD; ANALYSIS OF VARIANCE; CYTOTOXICITY TEST; GENETICS; HISTOCOMPATIBILITY TEST; IMMUNOASSAY; IMMUNOLOGY; LIVING DONOR; MIDDLE AGED; SURVIVAL;

ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; CHILD; CYTOTOXICITY TESTS, IMMUNOLOGIC; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS II; HISTOCOMPATIBILITY TESTING; HUMANS; IMMUNOASSAY; INFANT; ISOANTIBODIES; LIVER TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED; SURVIVAL ANALYSIS;

EID: 84879306200     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1155/2013/972705     Document Type: Article

References (13)

1. Sugawara Y., Tamura S., Kaneko J., Togashi J., Makuuchi M., Kokudo N., Positive lymphocytotoxic crossmatch does not adversely affect survival in living donor liver transplantation. Digestive Surgery 2010 26 6 482 486 2-s2.0-73649125010 10.1159/000253873
2. Ashihara E., Tsuji H., Sakashita H., Haga H., Yurugi K., Kimura S., Egawa H., Manabe T., Uemoto S., Maekawa T., Antidonor antibody in patients receiving ABO-identical and HLA-mismatched living donor liver transplants: effect on survival. Transplantation 2007 83 4 506 509 2-s2.0-33947514866 10.1097/01.tp.0000251361.12249.a1
3. Hori T., Uemoto S., Takada Y., Oike F., Ogura Y., Ogawa K., Miyagawa-Hayashino A., Yurugi K., Nguyen J. H., Hori Y., Chen F., Egawa H., Does a positive lymphocyte cross-match contraindicate living-donor liver transplantation? Surgery 2010 147 6 840 844 2-s2.0-77952312631 10.1016/j.surg.2009.11.022
4. Vaidya S., Partlow D., Susskind B., Noor M., Barnes T., Gugliuzza K., Prediction of crossmatch outcome of highly sensitized patients by single and/or multiple antigen bead luminex assay. Transplantation 2006 82 11 1524 1528 2-s2.0-33845694356 10.1097/01.tp.0000246311.43634.0a
5. Musat A. I., Agni R. M., Wai P. Y., Pirsch J. D., Lorentzen D. F., Powell A., Leverson G. E., Bellingham J. M., Fernandez L. A., Foley D. P., Mezrich J. D., D'Alessandro A. M., Lucey M. R., The significance of donor-specific HLA antibodies in rejection and ductopenia development in ABO compatible liver transplantation. The American Journal of Transplantation 2011 11 3 500 510 2-s2.0-79951976611 10.1111/j.1600-6143.2010.03414.x
6. + alloreactive responses toward early graft acceptance immediately after liver transplantation in humans. Liver Transplantation 2007 13 9 1262 1271 2-s2.0-34648825196 10.1002/lt.21232
7. Demetris A. J., Adeyi O., Bellamy C. O., Liver biopsy interpretation for causes of late liver allograft dysfunction. Hepatology 2006 44 2 489 501 2-s2.0-33747080802 10.1002/hep.21280
8. Haga H., Egawa H., Fujimoto Y., Ueda M., Miyagawa-Hayashino A., Sakurai T., Okuno T., Koyanagi I., Takada Y., Manabe T., Acute humoral rejection and C4d immunostaining in ABO blood type-incompatible liver transplantation. Liver Transplantation 2006 12 3 457 464 2-s2.0-33645321111 10.1002/lt.20652
9. Sakashita H., Haga H., Ashihara E., Wen M. C., Tsuji H., Miyagawa-Hayashino A., Egawa H., Takada Y., Maekawa T., Uemoto S., Manabe T., Significance of C4d staining in ABO-identical/compatible liver transplantation. Modern Pathology 2007 20 6 676 684 2-s2.0-34249056921 10.1038/modpathol.3800784
10. Wallace W. D., Reed E. F., Ross D., Lassman C. R., Fishbein M. C., C4d staining of pulmonary allograft biopsies: an immunoperoxidase study. Journal of Heart and Lung Transplantation 2005 24 10 1565 1570 2-s2.0-25844508502 10.1016/j.healun.2004.11.038
11. Creary L. E., Girdlestone J., Zamora J., Brown J., Navarrete C. V., Molecular typing of HLA genes using whole genome amplified DNA. Transfusion 2009 49 1 57 63 2-s2.0-58149141483 10.1111/j.1537-2995.2008.01943.x
12. Takaya S., Bronsther O., Iwaki Y., Nakamura K., Abu-Elmagd K., Yagihashi A., Demetris A. J., Kobayashi M., Todo S., Tzakis A. G., Fung J. J., Starzl T. E., The adverse impact on liver transplantation of using positive cytotoxic crossmatch donors. Transplantation 1992 53 2 400 406 2-s2.0-0026522576
13. Castillo-Rama M., Castro M. J., Bernardo I., Meneu-Diaz J. C., Elola-Olaso A. M., Calleja-Antolin S. M., Romo E., Morales P., Moreno E., Paz-Artal E., Preformed antibodies detected by cytotoxic assay or multibead array decrease liver allograft survival: role of human leukocyte antigen compatibility. Liver Transplantation 2008 14 4 554 562 2-s2.0-42149087047 10.1002/lt.21408